Table 5 Side effects: logistic regression analyses
From: The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
Side effect | Univariable results | Multivariable resultsa | ||||
|---|---|---|---|---|---|---|
Odds ratio CDMF vs CF | 95 % CI | p value | Odds ratio CDMF vs CF | 95 % CI | p value | |
Any side effect | 7.11 | 3.45, 14.62 | <0.001 | 7.49 | 3.54, 15.86 | <0.001 |
Abdominal pain | 14.16 | 3.77, 53.27 | <0.001 | 15.79 | 4.20, 59.41 | <0.001 |
Flushing | 12.92 | 6.12, 27.25 | <0.001 | 12.51 | 5.85, 26.76 | <0.001 |
Nausea | 3.28 | 1.45, 7.40 | 0.004 | 3.16 | 1.38, 7.24 | 0.007 |
Flu-like symptoms | 3.22 | 0.81, 12.84 | 0.097 | 3.02 | 0.77, 11.82 | 0.112 |
Diarrhea | 2.22 | 1.03, 4.77 | 0.041 | 2.30 | 1.06, 5.00 | 0.035 |
Cough | 1.33 | 0.51, 3.48 | 0.563 | 1.32 | 0.50, 3.44 | 0.574 |
Vomiting | 1.24 | 0.40, 3.89 | 0.712 | 1.26 | 0.41, 3.91 | 0.683 |
Back pain | 1.00 | 0.34, 2.91 | 0.995 | 0.94 | 0.33, 2.72 | 0.915 |
Headache | 0.85 | 0.43, 1.67 | 0.635 | 0.87 | 0.43, 1.73 | 0.687 |